title: Implementation of spacer therapy for acute asthma in children.
abstract: The aim was to develop and implement an evidence based guideline for the treatment of acute asthma using a metered dose inhaler and spacer combination. Children admitted to Cork University Hospital Paediatric Department with acute asthma were identified during two identical 2 month seasonal periods before (2005) and after (2006) implementation of the new guidelines in September 2006. Pre-intervention and post-intervention audits by case note review were performed to determine the impact of and compliance with this evidence-based guideline emphasising patient assessment, spacer delivered bronchodilator and specific discharge criteria. Patients had similar characteristics during the two study periods. There was a raised threshold for admission after guideline implementation with 11/52 patients having mild exacerbations in 2006, compared to 21/36 in 2005. Duration of admission was less in the post-implementation group for equivalent exacerbation severity e.g. for moderate severity; 28 hours in 2005, 23 hours in 2006. Duration of bronchodilator therapy was shorter in 2006 and more likely to be given by spacer device earlier for equivalent levels of severity e.g. for moderate exacerbations, in 2006 the average length of salbutamol therapy was 18 hours with 12 hours by spacer device, in 2005 the average length of therapy was 25 hours with 3 hours by spacer. There was earlier initiation of oral corticosteroids; the average time to administration was 56 minutes in 2006 and 227 minutes in 2005. There was an improved documentation of asthma education in 2006 e.g. inhaler technique was reviewed in 37/52 in 2006, 21/35 in 2005 and better use of written action plans.
authors.affiliation: Department of Paediatrics, Cork University Hospital, Wilton, Cork.
authors.forename: M
authors.initials: M
authors.lastname: Vandeleur
authors.forename: M N Ní
authors.initials: MN
authors.lastname: Chróinín
mesh_terms: D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000420:Albuterol / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004496:Education, Continuing; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007494:Ireland; D008297:Male; D055118:Medication Adherence; D036501:Metered Dose Inhalers; D017410:Practice Guidelines as Topic; D012017:Referral and Consultation; D012189:Retrospective Studies; D013997:Time Factors; D006113:United Kingdom
chemical_list: D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D000420:Albuterol